Fennec Pharmaceuticals Inc (FENC)
4.72
+0.08
(+1.72%)
USD |
NASDAQ |
Nov 21, 16:00
4.72
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Gross Profit Margin (Quarterly): 80.54% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 80.54% |
| June 30, 2024 | 91.63% |
| March 31, 2024 | 97.83% |
| December 31, 2023 | 92.96% |
| Date | Value |
|---|---|
| September 30, 2023 | 94.92% |
| June 30, 2023 | 95.55% |
| March 31, 2023 | 94.34% |
| December 31, 2022 | 94.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.54%
Minimum
Sep 2024
97.83%
Maximum
Mar 2024
92.77%
Average
94.37%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -2.39% |
| Return on Invested Capital | -4.49% |
| Profit Margin (Quarterly) | -82.23% |
| Operating Margin (Quarterly) | -74.89% |